DoD FY13 Prostate Cancer Idea Development Award | Apply Online

Opportunity Summary:

The DoD FY13 Prostate Cancer Idea Development Award (Funding Opportunity Number W81XWH-13-PCRP-IDA) is a funding program run through the Department of the Army, USAMRAA, under the Congressionally Directed Medical Research Programs (CDMRP) Prostate Cancer Research Program (PCRP). Its main purpose is to push prostate cancer research forward by supporting genuinely new, creative ideas that could make a meaningful contribution to the PCRP mission, even if those ideas involve some scientific risk. The mechanism has a long history (first offered in FY97), and by FY13 it had attracted 5,748 applications, with 1,029 ultimately recommended for funding, which gives a sense of both its popularity and competitiveness.

This award is specifically aimed at innovation rather than incremental progress. Successful projects are expected to introduce a new paradigm, challenge existing assumptions, reframe known problems in a novel way, or otherwise demonstrate a high level of creativity. The program explicitly notes that work that simply extends already published findings in a stepwise manner is not considered innovative for this mechanism. At the same time, the DoD makes it clear that innovation does not mean speculation without support. Applications should be grounded in a sound scientific rationale built through logical reasoning and/or a critical assessment of existing literature. Preliminary data related to prostate cancer and the proposed project is encouraged because it can strengthen credibility, but it is not required, reflecting the program's willingness to consider earlier-stage concepts when the logic is compelling.

The scope is intentionally broad, welcoming proposals across the research spectrum, including basic science, population-based research, translational studies, and clinical research. Applicants are expected to align their work with at least one of the PCRP focus areas and are strongly encouraged to address one of the PCRP overarching challenges. If a project does not target one of those overarching challenges, the application is expected to clearly justify why the work still addresses a critical unmet need in prostate cancer research and/or patient care, signaling that relevance and potential impact are central review considerations even when a proposal falls outside the highlighted challenge themes.

A major feature of the FY13 cycle is the New Investigator Option, which is designed to help investigators early in their careers compete on a more level playing field. Under this option, New Investigators and Established Investigators are reviewed in separate peer and programmatic review pools, reducing direct competition between early-career applicants and long-established labs. New Investigators are strongly encouraged to build collaborations with researchers who have prostate cancer experience or complementary expertise, and the principal investigator is responsible for explaining how those collaborations fill gaps and strengthen the team's ability to answer the research question. Eligibility for the New Investigator track is not automatic; applicants must meet specific criteria described in the full announcement's eligibility section.

From an administrative standpoint, the opportunity was posted May 13, 2013, with an original and final closing date of October 2, 2013, and it was archived November 1, 2013. The funding instrument type is listed as a cooperative agreement and grant, categorized under science and technology and other research and development, with CFDA 12.420 (Military Medical Research and Development). The program anticipated making about 32 awards with an estimated total funding level of $17.3 million, and it did not require cost sharing or matching. Eligibility is described as unrestricted (open to any type of entity), subject to any additional clarifications in the full text of the announcement.

For applicants needing help accessing the complete announcement, the listed point of contact is the CDMRP Help Desk at 301-682-5507.

Browse more opportunities from the same agency: Dept. of the Army USAMRAA

Browse more opportunities from the same category: Science and Technology and other Research and Development

Next opportunity: DoD FY13 Prostate Cancer Synergistic Idea Development Award

Previous opportunity: DoD Ovarian Cancer Clinical Translational Leverage Award

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for W81XWH 13 PCRP IDA

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (W81XWH 13 PCRP IDA) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 13 PCRP IDA", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.